News / Sep 18, 2018
FDA OPQ Training at Hovione New Jersey Site
Hovione New Jersey welcomes a Team from the FDA for a Training on Continuous Manufacturing
Hovione was celebrating rapid growth, evident in expansions at their New Jersey site and increased pilot capabilities in Portugal. Filipe Tomas, General Manager, explained that the New Jersey expansion adds a new commercial spray dryer, and more than doubles the site’s capacity to manufacture API and intermediates. Phase 1 will be completed in June 2017, with the next major milestone – expansion of continuous drug product manufacturing – expected in March 2018.